Year: 2017
Type: dissertation
Abstract: In the past, weight loss surgery was often perceived as cosmetic surgery as it was primarily aiming at restoring normal weight. However, once the favorable effects of surgery on obesity related diseases such as type 2 diabetes (T2D), sleep apnea, hypertension and even cancer became apparent, the attitude towards weight loss surgery changed profoundly. In particular, the observed improvement or even disappearance of T2D after surgery has been a game changer for the acceptance of these procedures by health care providers. At first the impressive effect of surgery on the sugar levels in patients suffering from T2D was completely attributed to the profound weight loss surgery induces. Surprisingly, further research showed that this improvement was already present before any significant amount of weight was lost and that equal weight obtained by merely decreasing food intake by for example banding of the stomach did not achieve the same benefits as observed when a stomach reduction or bridging operation was performed (sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB)). Researchers across the globe have been trying to understand the reason for this differential effect on T2D of weight loss per se versus weight loss induced by RYGB or SG. Let us first explore how T2D comes about. Sugar is the fuel of our body. The sugar we eat or that is produced in our liver is transported to the organs, but in order for sugar to enter the organ, e.g. the muscles, it needs the help of the janitor, insulin. Someone with T2D requires more janitors to help sugar enter the organs, a phenomenon that is referred to as insulin resistance. Insulin resistance occurs in obese individuals, because the organs have plentiful energy from other sources, i.e. the excess stored fat. The heavier the person, the more his organs will become insulin resistant. However, in normal individuals more janitors are hired, in other words more insulin is produced to help sugar enter the organs and maintain normal sugar levels in the blood. However, a number of patients are unable to increase insulin production by the beta-cells in the pancreas and as a result sugar levels in the blood rise and T2D develops. It is possible that RYGB and SG have direct effects on the insulin-producing beta-cells, thus restoring insulin production and normal sugar levels in the blood. We tried to find evidence for improved beta-cell function after SG and RYGB by inducing high blood sugar levels and measuring the beta-cells' capacity.to produce enough insulin to compensate for this rise. In addition, we looked at whether people who lack beta-cells because of their auto-immune destruction (type 1 diabetes) and are thus dependent on self-administered exogenous insulin, see their sugar levels improved following SG and RYGB. However, the decrease of sugar levels is sometimes exaggerated after SG and RYGB, in particular when the insulin producing beta-cells are overstimulated by the more rapid increase in blood sugar after SG and RYGB. The latter is due to the more rapid absorption of sugar in the blood as ingested sugar reaches the small intestine more rapidly after surgery. However sometimes it occurs without food intake for reasons that are not well understood. These sudden drops in sugar levels are extremely unpleasant and sometimes lead to loss of consciousness as the main source of energy for the brain is glucose. We tried to understand the mechanisms that provoke these low blood sugars in patients that complain of symptoms resembling sugar drops. To exclude the influence of meals we tried to induce an abnormal drop in blood sugar through moderate and vigorous exercise. We also explored new treatments for people that experience this troublesome side-effect Below we summarize our most relevant findings 1 / In patients lacking beta-cells, i.e. patients suffering from type 1 diabetes, there was no improvement of blood sugar levels following RYGB or SG, suggesting the improvement observed in patients with T2D, that still have remaining, albeit diseased, beta-cells, might at least partly be explained by restoring the insulin secreting capacity of those cells. However the patients with type 1 diabetes needed to inject far less insulin than before the surgical intervention, clearly demonstrating a drop in insulin resistance when weight is lost. 2 / We selected a group of patients with very severe T2D and thus very diseased beta-cells. This group of 30 patients was randomly assigned to either SG, RYGB or a very stringent protein diet. By inducing hyperglycemia, we checked whether the ability of the beta-cells to secrete insulin was improved 3 weeks after either surgery or diet. We found clear evidence that SG and RYGB improved the beta-cell functionality to a greater extent than when a stringent diet was imposed. 3. We selected a group of patients complaining of meal-unrelated sugar drops. We were unable to induce low sugar blood values, but did observe abnormalities in insulin suppression during moderate exercise and sugar increase following vigorous exercise, suggesting abnormalities in the regulation of blood sugar levels in this selected patient population. 4. In another group of patients complaining of meal related sugar drops, we demonstrated the efficacy of a new treatment with Pasireotide in preventing low sugar levels following sugar ingestion.
Source: Lirias
Author: Lannoo, M.
Institution: KU Leuven
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7062288595
